A developing number of individuals burning-through liquor and illegal drugs, for example, cannabis and cocaine is transcendently powering the development of Asia Pacific drugs of abuse testing devices market. As per the report distributed by India Today in June 2019, the studies in India in 2018 and Nigeria in 2017 have offered extraordinary experiences into drug utilization due to being such immense socioeconomics for their area. India represents 30% of the populace in Asia alone. The report uncovers that of the 271 million individuals that utilized any drug, 35 million (almost 13 percent) experience the ill effects of a drug use problem.
Key Developments:
In January 2019, two new pee drug screens got endorsement for snappy In-Office Testing. The iCUP Rx Drug Screen, presented by Alere (Waltham, Massachusetts), conveys drug levels for five of the most regularly abused narcotic inferred drugs. The second new test, the Sefria Drug Screening Kit, is the sole accessible in-office item to empower doctors to screen for the presence of fentanyl; the Sefria unit is accessible from Immunalysis Corporation, a division of Alere.
To know the latest trends and insights prevalent in this market, click the link below:

No comments:
Post a Comment